Reuters logo
BRIEF-Immunomedics announces Q2 fiscal 2017 results and clinical program developments
February 9, 2017 / 9:08 PM / 10 months ago

BRIEF-Immunomedics announces Q2 fiscal 2017 results and clinical program developments

Feb 9 (Reuters) - Immunomedics Inc

* Immunomedics announces second quarter fiscal 2017 results and clinical program developments

* Immunomedics Inc says total costs and expenses for quarter ended December 31, 2016 were $15.7 million, compared to $16.4 million for same quarter in fiscal 2016

* Q2 loss per share $0.23

* Q2 revenue fell 43 percent to $400,000 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below